Product
FG-3019
2 clinical trials
2 indications
Indication
Idiopathic Pulmonary FibrosisIndication
Pancreatic CancerClinical trial
A Phase 1 Study of the Safety, Pharmacokinetics, and Biologic Activity of Escalating Doses of FG-3019 in Subjects With Idiopathic Pulmonary FibrosisStatus: Completed
Clinical trial
A Randomized, Open Label, Phase 1/2 Trial of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 as Neoadjuvant Chemotherapy in Locally Advanced, Unresectable Pancreatic CancerStatus: Completed, Estimated PCD: 2021-12-15